More people
The U.S. population grew from 253.0 million in 1991 to 340.0 million in 2024. That is roughly 87 million more people in the denominator and more people exposed to cancer risk.
From systems to signals.
U.S. cancer mortality · 1991–2024
Both statements are true. The difference is what each number is asked to measure.
Annual observation
Rate per 100,000, adjusted to the 2000 U.S. standard population.
Thirty-three years. One consistent direction.
The interactive scene is unavailable, but every chart and explanation below remains available.
Preparing the annual record…
01 · THE APPARENT PARADOX
A death count measures the total human burden. An age-adjusted death rate measures risk after holding the population’s age structure constant. One went up. The other came down.
514,657 people died of cancer in 1991. In 2024, the recorded total was 619,871. Over the same span, the age-adjusted rate fell from 215.16 to 139.10 deaths per 100,000.
THE DIVERGENCE
Index: 1991 = 100. Select any point for the underlying values.
Sources: SEER (rates); NCHS / CDC U.S. Cancer Statistics (counts). 2024 is the latest observed year.
THE NUMERATOR
Recorded cancer deaths, United States
About 105,000 more deaths in 2024 than in 1991.
THE STANDARDIZED RISK
Age-adjusted deaths per 100,000
Age adjustment uses the 2000 U.S. standard population.
The falling rate does not make the additional deaths less real. It tells us that the count is being shaped by more than individual cancer risk. To understand the total, look at the population underneath it.
02 · START WITH THE DENOMINATOR
The crude death rate divides deaths by the number of people alive. A larger population can produce more deaths even when the rate is lower.
The U.S. population grew from 253.0 million in 1991 to 340.0 million in 2024. That is roughly 87 million more people in the denominator and more people exposed to cancer risk.
Cancer mortality is generally higher at older ages. When the older share grows, the total count can rise even if risk within each age group falls.
Prevention, earlier detection, and treatment reduce deaths within age groups. Age adjustment keeps those improvements visible instead of letting changing age structure dominate the comparison.
THE POPULATION EFFECT
Total U.S. population, selected years. Hover or focus each point.
Source: World Bank Open Data, SP.POP.TOTL, accessed October 2026.
How many people died?
Use it for total burden, staffing, treatment capacity, and the number of families affected.How common was death relative to the population?
Use it to compare risk across places and periods, especially after accounting for age.03 · AGE CHANGES THE TOTAL
In 1991, about 12.4% of Americans were 65 or older. By 2024, the share was 17.9%. Because the total population also grew, the estimated number of people 65+ rose from about 31.2 million to 61.0 million.
A LARGER, OLDER COUNTRY
Bars: people aged 65+. Line: share of the total population aged 65+.
Source: World Bank Open Data. 65+ counts derived from total population × 65+ share.
1991
31.2 million people aged 65+
2024
61.0 million people aged 65+
A population with more older adults can record more cancer deaths even when every age group becomes safer. This is the central reason a rising count does not contradict a falling age-adjusted rate.
04 · A WORKED EXAMPLE
This simplified community is illustrative, not U.S. data. Both age groups become 20% safer. The population grows and becomes older. Total deaths rise, while the crude and age-adjusted rates fall.
| Measure | Then | Now | What changed |
|---|---|---|---|
| Younger population | 1,800 | 2,500 | More people |
| Older population | 200 | 500 | Older share: 10% → 16.7% |
| Risk per 1,000 younger people | 10 | 8 | 20% lower |
| Risk per 1,000 older people | 50 | 40 | 20% lower |
| Total deaths | 28 | 40 | 42.9% higher |
| Crude rate per 1,000 | 14.0 | 13.3 | Lower despite more deaths |
| Age-adjusted index, equal age weights | 30.0 | 24.0 | 20% lower |
Then: (1,800 × 10/1,000) + (200 × 50/1,000) = 28 deaths. Now: (2,500 × 8/1,000) + (500 × 40/1,000) = 40 deaths. Each group is safer. The total is larger.
05 · CRUDE VERSUS AGE-ADJUSTED
A crude rate uses the population as it actually was. An age-adjusted rate calculates age-specific rates first, then applies the same standard age weights to every year.
Deaths ÷ population in each age group.
Multiply by the same standard population distribution.
Compare years without letting age structure change the yardstick.
SAME DEATHS, DIFFERENT QUESTION
CDC WONDER observations, 1999–2020. The crude rate reflects actual age structure; the adjusted rate uses the 2000 standard.
Source: CDC WONDER D76, ICD-10 C00–C97. Small differences from SEER can reflect population-estimate sources.
An age-adjusted rate is a comparison index, not the actual number of deaths expected in the current population. Do not multiply it by the current total population to reconstruct the count.
06 · WHY RISK FELL
The American Cancer Society attributes the long decline largely to less smoking, earlier detection for some cancers, and better treatment. These forces lower risk; they do not stop the population from growing or aging.
cancer deaths averted from 1991 through 2023, according to the American Cancer Society’s comparison with peak mortality rates. This is an estimated counterfactual, not a count of named individuals.
National averages can hide substantial differences by cancer type, race, ethnicity, income, geography, and access to care. A falling national rate is not evidence that every group improved equally.
07 · USE THE RIGHT MEASURE
The measures are partners, not competitors. A hospital, a state, and a researcher may all need both.
USE COUNTS TO PLAN
USE RATES TO COMPARE
“More deaths” does not prove that progress stopped. “Lower rates” does not mean the burden disappeared.
08 · METHODS AND SOURCES
All figures describe underlying deaths from malignant neoplasms in the United States. Rates are per 100,000 people and age-adjusted to the 2000 U.S. standard population unless stated otherwise. All values are observed records, not 2026 projections.
The main comparison uses 1991, the peak year cited by the American Cancer Society, through 2024, the latest observed year in CDC’s 2026 release. The 3D scene spans 1991–2024: a 1991 baseline center point and 33 annual rings for 1992–2024.
SEER supplies the rate series. Counts combine NCHS historical records with CDC WONDER and U.S. Cancer Statistics. Population estimates come from the World Bank. Minor differences between agencies can reflect population-estimate vintages.
Percentage changes and age-65+ counts are calculated from the displayed source series. The two-period community in section 04 is synthetic and exists only to demonstrate the arithmetic.